Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - TOTAL CURRENT ASSETS
Total Current Assets FATE - Fate Therapeutics, Inc.
332 M
LAST VALUE
-27.65%
2 YEAR CAGR
10.07%
5 YEAR CAGR
19.76%
10 YEAR CAGR